EUVIMED · CrossrefJournal
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
ISSN 2352-8729 · Wiley
Latest articles
Blood TRPC6 mRNA as a biomarker for Alzheimer's disease: a nationwide, multicenter study in China
Multi‐platform comparison of plasma phosphorylated tau assays: analytical and workflow factors drive clinical implementation decisions
The GFAP/NfL ratio does not outperform NfL or GFAP in genetic frontotemporal dementia
Choroid plexus biomarkers capture neuroinflammatory processes associated with amyloid and neurodegeneration in Alzheimer's disease
Modifiable dementia risk factors and socioeconomic differences in a diverse aging cohort
Early anhedonia distinguishes behavioral variant frontotemporal dementia from Alzheimer's disease
Cognitive and brain reserve in bilingual speakers with clinical AD variants
Decomposed arterial stiffness and NfL–cognition association in older adults: The IGNITE study
Depression and loneliness differentially predict visual hallucinations in veterans with Alzheimer's disease and Lewy body dementia
Neuropsychiatric symptoms across the revised Alzheimer's disease clinical staging framework: A review of current evidence and implications
Predicting mild cognitive impairment from simulated driving performance: A preliminary investigation
Diffusion MRI metrics of white matter association tracts are associated with cognitive migration in older adults without dementia
Diagnostic reversion in dementia care: A real‐world analysis of mild cognitive impairment diagnoses after dementia in a large electronic medical record system
Differences in anti‐amyloid therapy eligibility assessment based on use of the SWI versus GRE sequence
Characterizing cognitive concerns in subjective cognitive decline using large language models and electronic health record notes
Comparing criteria for objective cognitive staging in preclinical Alzheimer's disease
Remote versus in‐person cognitive testing: the impact of visit modality on longitudinal cognitive outcomes in older adults
Mini‐Mental State Examination trajectories across dementia subtypes in the Swedish Registry for Cognitive/Dementia Disorders and U.S. National Alzheimer's Coordinating Center
Modifiable risk factors for mild cognitive impairment: Insights from a 7‐year follow‐up cohort study among Shanghai community‐dwelling older adults
Item‐level verbal fluency psycholinguistic metrics predict preclinical Alzheimer's disease
Global, regional, and national burden of anxiety‐related Alzheimer's disease and Alzheimer's‐related dementias among older adults from 1995 to 2021: A comparative risk assessment study
Principal component analysis‐derived magnetic resonance imaging brain fluid dynamics‐related composite in the Alzheimer's spectrum
Spatial patterns of amyloid clearance after donanemab: A preliminary 12‐month real‐world amyloid PET study in Japanese patients with early Alzheimer's disease
Plasma biomarker signatures in patients with rapidly progressive dementia
Dementia in individuals with intellectual disabilities: An exploratory study of prevalence and mortality risk using Dutch routine care and population data
Real‐world evidence for amyloid‐targeted therapies: Lecanemab and donanemab
Independent prognostic value of peak width of skeletonized mean diffusivity on clinical progression in Alzheimer's disease
Experience with donanemab over a 1‐year period: observations of side effects and compliance from a regional specialty medical center
Stigma, isolation, and depression in Chinese and Korean American dementia caregivers
Interchangeability of CSF and PET to identify Alzheimer's disease pathology
EUVIMED